Literature DB >> 22322310

Quantitative evaluation of contrast-enhanced ultrasound after intravenous administration of a microbubble contrast agent for differentiation of benign and malignant thyroid nodules: assessment of diagnostic accuracy.

Ursula Nemec1, Stefan F Nemec, Clemens Novotny, Michael Weber, Christian Czerny, Christian R Krestan.   

Abstract

OBJECTIVES: To investigate the diagnostic accuracy, through quantitative analysis, of contrast-enhanced ultrasound (CEUS), using a microbubble contrast agent, in the differentiation of thyroid nodules.
METHODS: This prospective study enrolled 46 patients with solitary, scintigraphically non-functional thyroid nodules. These patients were scheduled for surgery and underwent preoperative CEUS with pulse-inversion harmonic imaging after intravenous microbubble contrast medium administration. Using histology as a standard of reference, time-intensity curves of benign and malignant nodules were compared by means of peak enhancement and wash-out enhancement relative to the baseline intensity using a mixed model ANOVA. ROC analysis was performed to assess the diagnostic accuracy in the differentiation of benign and malignant nodules on CEUS.
RESULTS: The complete CEUS data of 42 patients (31/42 [73.8%] benign and 11/42 [26.2%] malignant nodules) revealed a significant difference (P < 0.001) in enhancement between benign and malignant nodules. Furthermore, based on ROC analysis, CEUS demonstrated sensitivity of 76.9%, specificity of 84.8% and accuracy of 82.6%.
CONCLUSIONS: Quantitative analysis of CEUS using a microbubble contrast agent allows the differentiation of benign and malignant thyroid nodules and may potentially serve, in addition to grey-scale and Doppler ultrasound, as an adjunctive tool in the assessment of patients with thyroid nodules. KEY POINTS: • Contrast-enhanced ultrasound (CEUS) helps differentiate between benign and malignant thyroid nodules. • Quantitative CEUS analysis yields sensitivity of 76.9% and specificity of 84.8%. • CEUS may be a potentially useful adjunct in assessing thyroid nodules.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22322310     DOI: 10.1007/s00330-012-2385-6

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  32 in total

1.  Contrast-enhanced ultrasound examination of lymph nodes in different types of lymphoma.

Authors:  Kazunori Nakase; Kouji Yamamoto; Atsunori Hiasa; Isao Tawara; Motoko Yamaguchi; Hiroshi Shiku
Journal:  Cancer Detect Prev       Date:  2006-05-02

2.  Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement.

Authors:  Mary C Frates; Carol B Benson; J William Charboneau; Edmund S Cibas; Orlo H Clark; Beverly G Coleman; John J Cronan; Peter M Doubilet; Douglas B Evans; John R Goellner; Ian D Hay; Barbara S Hertzberg; Charles M Intenzo; R Brooke Jeffrey; Jill E Langer; P Reed Larsen; Susan J Mandel; William D Middleton; Carl C Reading; Steven I Sherman; Franklin N Tessler
Journal:  Radiology       Date:  2005-12       Impact factor: 11.105

3.  Technology overview: SonoVue (Bracco, Milan).

Authors:  Christian Greis
Journal:  Eur Radiol       Date:  2004-10       Impact factor: 5.315

4.  Isolated thyroid metastasis from renal cell carcinoma.

Authors:  Ah-Young Kim; Sung Bin Park; Hee Seok Choi; Jae Cheol Hwang
Journal:  J Ultrasound Med       Date:  2007-12       Impact factor: 2.153

5.  Vascular pattern and spectral parameters of power Doppler ultrasound as predictors of malignancy risk in thyroid nodules.

Authors:  Mehdi Bakhshaee; Yasamin Davoudi; Mostafa Mehrabi; Parvin Layegh; Saadat Mirsadaee; Masoud Pezeshki Rad; Parvaneh Leyegh
Journal:  Laryngoscope       Date:  2008-12       Impact factor: 3.325

Review 6.  Use of color Doppler ultrasonography for the prediction of malignancy in follicular thyroid neoplasms: systematic review and meta-analysis.

Authors:  Wagner Iared; David Carlos Shigueoka; Júlio Cesar Cristófoli; Regis Andriolo; Alvaro Nagib Atallah; Sérgio Aron Ajzen; Orsine Valente
Journal:  J Ultrasound Med       Date:  2010-03       Impact factor: 2.153

7.  Comparing contrast-enhanced ultrasound to immunohistochemical markers of angiogenesis in a human melanoma xenograft model: preliminary results.

Authors:  Flemming Forsberg; Adam P Dicker; Mattew L Thakur; Nandkumar M Rawool; Ji-Bin Liu; William T Shi; Levon N Nazarian
Journal:  Ultrasound Med Biol       Date:  2002-04       Impact factor: 2.998

8.  Characterization of single thyroid nodules by contrast-enhanced 3-D ultrasound.

Authors:  Filippo Molinari; Alice Mantovani; Maurilio Deandrea; Paolo Limone; Roberto Garberoglio; Jasjit S Suri
Journal:  Ultrasound Med Biol       Date:  2010-10       Impact factor: 2.998

9.  Second generation ultrasonographic contrast agents in the diagnosis of neoplastic thyroid nodules.

Authors:  M Appetecchia; D Bacaro; R Brigida; D Milardi; A Bianchi; F Solivetti
Journal:  J Exp Clin Cancer Res       Date:  2006-09

10.  Fine-needle aspiration biopsy of thyroid nodules: experience in a cohort of 944 patients.

Authors:  Nina D Baier; Peter F Hahn; Debra A Gervais; Anthony Samir; Elkan F Halpern; Peter R Mueller; Mukesh G Harisinghani
Journal:  AJR Am J Roentgenol       Date:  2009-10       Impact factor: 3.959

View more
  27 in total

1.  Quantitative analysis of suspicious thyroid nodules by contrast-enhanced ultrasonography.

Authors:  Yizhou Hu; Ping Li; Shufei Jiang; Fenghua Li
Journal:  Int J Clin Exp Med       Date:  2015-07-15

2.  Diagnostic value of contrast-enhanced ultrasound in solid thyroid nodules with and without enhancement.

Authors:  Qiong Wu; Yan Wang; Yi Li; Bing Hu; Zhi-Yan He
Journal:  Endocrine       Date:  2016-01-05       Impact factor: 3.633

3.  Accuracy of contrast-enhanced ultrasound in the identification of thyroid nodules: a meta-analysis.

Authors:  Biyun Sun; Lin Lang; Xiangming Zhu; Feng Jiang; Yun Hong; Lianping He
Journal:  Int J Clin Exp Med       Date:  2015-08-15

4.  Evaluation of thyroid cancer in Chinese females with breast cancer by vascular endothelial growth factor (VEGF), microvessel density, and contrast-enhanced ultrasound (CEUS).

Authors:  Xi Wei; Ying Li; Sheng Zhang; Gao Ming
Journal:  Tumour Biol       Date:  2014-04-01

5.  Brain tumor classification on intraoperative contrast-enhanced ultrasound.

Authors:  Kai Ritschel; Ioannis Pechlivanis; Susanne Winter
Journal:  Int J Comput Assist Radiol Surg       Date:  2014-06-24       Impact factor: 2.924

6.  Association between real-time contrast-enhanced ultrasound characteristics and thyroid carcinoma size.

Authors:  Zhang Yuan; Jiang Quan; Zhang Yunxiao; Chen Jian; H E Zhu
Journal:  Mol Clin Oncol       Date:  2015-05-15

7.  Contrast-enhanced ultrasound (CEUS) facilitated US in detecting lateral neck lymph node metastasis of thyroid cancer patients: diagnosis value and enhancement patterns of malignant lymph nodes.

Authors:  Dapeng Xiang; Yurong Hong; Bo Zhang; Pintong Huang; Guogang Li; Ping Wang; Zhiyu Li
Journal:  Eur Radiol       Date:  2014-07-09       Impact factor: 5.315

8.  Contrast-enhanced ultrasound and real-time elastography in the differential diagnosis of malignant and benign thyroid nodules.

Authors:  Xin Sui; Huai-Jun Liu; Hong-Li Jia; Qin-Mao Fang
Journal:  Exp Ther Med       Date:  2016-05-17       Impact factor: 2.447

9.  Performance of contrast-enhanced ultrasound (CEUS) in assessing thyroid nodules: a systematic review and meta-analysis using histological standard of reference.

Authors:  Pierpaolo Trimboli; Marco Castellana; Camilla Virili; Roald Flesland Havre; Fabiano Bini; Franco Marinozzi; Ferdinando D'Ambrosio; Francesco Giorgino; Luca Giovanella; Helmut Prosch; Giorgio Grani; Maija Radzina; Vito Cantisani
Journal:  Radiol Med       Date:  2020-01-22       Impact factor: 3.469

10.  The features of contrast enhanced ultrasound and BRAF V600E in papillary thyroid carcinoma.

Authors:  Zi-Mei Lin; Cao-Xin Yan; Yue Song; Yu-Rong Hong; Qing Wen; Yong-Yuan Xu; Min-Qiang Pan; Qin Ye; Pin-Tong Huang
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.